Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

First Installation of IMRISNV and IMRISneuro to be at New Smilow Cancer Hospital

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Daiichi Sankyo, GAIA Partner on Lipodia...

Pharmaceutical companies are increasingly integrating digital health tools with...

Medtronic Expands Strategic Alliance with GE...

Medtronic has entered into a multi-year renewal and significant...

UK Medical Device Testing Jumps 17%,...

Clinical investigations of medical devices in the UK reached...

IMRIS Inc. announced the sale of IMRISNV to Connecticut-based Yale-New Haven Hospital, the primary teaching hospital for the Yale School of Medicine. With installation later this year, Yale-New Haven Hospital will become the first hospital in the world with IMRISNV’s unique capability of allowing both 3 Tesla MRI and bi-plane x-ray angiography in a single suite without the need to transport the patient between modalities. The IMRIS suite will be installed at the Hospital’s new Smilow Cancer Hospital building and will include an interventional theater for neurovascular procedures, an MR diagnostic center and an operating room for neurosurgery. Earlier in the year, Yale-New Haven purchased an IMRISneuro system which will be part of the fully integrated suite.

The IMRIS suite features a bi-plane angiography system in the interventional theater and a wide bore 3T MRI scanner. The MRI can be deployed into any of the three rooms, permitting rapid and efficient transitions between MR imaging and surgery or intervention without transporting the patient between modalities. MR images can be taken before and during procedures to assess tissue condition, and can also be used in conjunction with fluoroscopic images during neurovascular procedures. On completion, new images can be taken to evaluate the surgery or intervention.

MEDICAL FAIR ASIA 2026

Latest stories

Related stories

Daiichi Sankyo, GAIA Partner on Lipodia Digital Therapeutics

Pharmaceutical companies are increasingly integrating digital health tools with...

Medtronic Expands Strategic Alliance with GE HealthCare

Medtronic has entered into a multi-year renewal and significant...

UK Medical Device Testing Jumps 17%, AI and Neurotech Lead

Clinical investigations of medical devices in the UK reached...

Medtronic Secures FDA PMA for Infuse Bone Graft in TLIF

Medtronic announced that it has secured FDA premarket approval...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »